newsfilter
← Latest News
FDA Approved Drugs·

Approval of KANJINTI, BLA #761073

Approval Date: 11/09/2026 Drug Name: KANJINTI, BLA #761073 Submission: SUPPL-12 Active Ingredients: TRASTUZUMAB-ANNS Company: AMGEN INC Submission Status: Approval Application Number: 761073

Company
AMGEN INC
Keywords
TRASTUZUMAB-ANNS